- Home
- Software Solutions
- Resources
- Corporate
A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza
Sponsors:
| Phases:
| |
| Indications | Acronym: AVX502-003 | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 72 | |
Additional information about NCT00706732.